These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 16929622)

  • 21. Imaging of hepatocellular carcinoma: current concepts.
    Parikh A; Taouli B
    Recent Results Cancer Res; 2013; 190():33-55. PubMed ID: 22941012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocellular nodules in liver cirrhosis: MR evaluation.
    Lee JM; Choi BI
    Abdom Imaging; 2011 Jun; 36(3):282-9. PubMed ID: 21399975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Epidemiology and diagnosis of hepatocellular carcinomas in cirrhosis].
    Duvoux C
    Ann Chir; 1998; 52(6):511-7. PubMed ID: 9752500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 70-year-old woman with 10 years of markedly elevated alpha-fetoprotein measurements.
    Hsu SX; Siegel AB; Berk PD
    Semin Liver Dis; 2010 Feb; 30(1):99-106. PubMed ID: 20175037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocellular carcinoma: Advances in diagnostic imaging.
    Sun H; Song T
    Drug Discov Ther; 2015 Oct; 9(5):310-8. PubMed ID: 26632539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Screening for hepatocellular carcinoma].
    Leone N; Rizzetto M
    Minerva Med; 2005 Apr; 96(2):95-108. PubMed ID: 16172579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.
    Egger C; Goertz RS; Strobel D; Lell M; Neurath MF; Knieling F; Scharf M
    Ultraschall Med; 2012 Dec; 33(6):587-92. PubMed ID: 23154871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative evaluation of echography, computerized tomography and magnetic resonance imaging in the diagnosis of hepatocellular carcinoma in cirrhotic patients].
    Dalla Palma L; Pozzi-Mucelli RS; Bazzocchi M; Pozzi-Mucelli R; Ferrara P
    Radiol Med; 1991; 81(1-2):8-15. PubMed ID: 1848720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma.
    Manini MA; Sangiovanni A; Fornari F; Piscaglia F; Biolato M; Fanigliulo L; Ravaldi E; Grieco A; Colombo M;
    J Hepatol; 2014 May; 60(5):995-1001. PubMed ID: 24462368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MRI in detection of hepatocellular carcinoma (HCC).
    Digumarthy SR; Sahani DV; Saini S
    Cancer Imaging; 2005 Apr; 5(1):20-4. PubMed ID: 16154814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis.
    Sangiovanni A; Manini MA; Iavarone M; Romeo R; Forzenigo LV; Fraquelli M; Massironi S; Della Corte C; Ronchi G; Rumi MG; Biondetti P; Colombo M
    Gut; 2010 May; 59(5):638-44. PubMed ID: 19951909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging.
    Quaia E; Pizzolato R; De Paoli L; Angileri R; Ukmar M; Cova MA
    J Magn Reson Imaging; 2013 Apr; 37(4):892-902. PubMed ID: 23097278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations.
    Libbrecht L; Bielen D; Verslype C; Vanbeckevoort D; Pirenne J; Nevens F; Desmet V; Roskams T
    Liver Transpl; 2002 Sep; 8(9):749-61. PubMed ID: 12200773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From the RSNA refresher courses: screening the cirrhotic liver for hepatocellular carcinoma with CT and MR imaging: opportunities and pitfalls.
    Baron RL; Peterson MS
    Radiographics; 2001 Oct; 21 Spec No():S117-32. PubMed ID: 11598252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
    De Cobelli F; Castrucci M; Sironi S; Livraghi T; Venturini M; Salvioni M; Del Maschio A
    Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Focal lesions in the cirrhotic liver: their pivotal role in gadoxetic acid-enhanced MRI and recognition by the Western guidelines.
    Golfieri R; Garzillo G; Ascanio S; Renzulli M
    Dig Dis; 2014; 32(6):696-704. PubMed ID: 25376286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modern diagnosis and management of hepatocellular carcinoma.
    Marrero JA; Welling T
    Clin Liver Dis; 2009 May; 13(2):233-47. PubMed ID: 19442916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver cancer in Malaysia: epidemiology and clinical presentation in a multiracial Asian population.
    Goh KL; Razlan H; Hartono JL; Qua CS; Yoong BK; Koh PS; Abdullah BJ
    J Dig Dis; 2015 Mar; 16(3):152-8. PubMed ID: 25512092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening and detection of hepatocellular carcinoma.
    Simpson HN; McGuire BM
    Clin Liver Dis; 2015 May; 19(2):295-307. PubMed ID: 25921664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The diagnostic approach to hepatocellular carcinoma].
    Schacherer D; Schoelmerich J; Zuber-Jerger I
    Z Gastroenterol; 2007 Oct; 45(10):1067-74. PubMed ID: 17924305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.